Artal Group S.A. - MINK THERAPEUTICS INC ownership

MINK THERAPEUTICS INC's ticker is and the CUSIP is 603693102. A total of 26 filers reported holding MINK THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Artal Group S.A. ownership history of MINK THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2
-99.6%
1,916
-99.2%
0.00%
-100.0%
Q2 2023$479
-12.8%
228,216
-21.2%
0.02%
-54.5%
Q1 2023$549
-27.4%
289,5880.0%0.03%
-21.4%
Q4 2022$756
-99.9%
289,5880.0%0.04%
+61.5%
Q3 2022$611,000
+49.8%
289,5880.0%0.03%
+18.2%
Q2 2022$408,000
-37.4%
289,5880.0%0.02%
-18.5%
Q1 2022$652,000
-49.5%
289,5880.0%0.03%
-22.9%
Q4 2021$1,292,000289,5880.04%
Other shareholders
MINK THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
ORACLE INVESTMENT MANAGEMENT INC 36,898$40,5880.01%
Covestor Ltd 1,078$10.00%
UBS OCONNOR LLC 21,590$25,2600.00%
ROYAL BANK OF CANADA 649$1,0000.00%
Allworth Financial LP 2$30.00%
VANGUARD GROUP INC 234,182$257,6000.00%
Artal Group S.A. 1,916$20.00%
CHILTON CAPITAL MANAGEMENT LLC 309$3400.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 5,066$5,9270.00%
UBS Group AG 3,547$3,9020.00%
View complete list of MINK THERAPEUTICS INC shareholders